63 related articles for article (PubMed ID: 8347864)
1. [The effect of Habu toxoid--from the view point of public health center].
Uda H; Tomari T; Yanagihashi T; Nozaki M; Kodama K
Nihon Koshu Eisei Zasshi; 1993 Jun; 40(6):482-90. PubMed ID: 8347864
[TBL] [Abstract][Full Text] [Related]
2. [Preventive studies on habu snake (Trimeresurus flavoviridis) bites with its venom toxoid. 1. Side-effects and increase of serum antibody level by the toxoid vaccination in the Amami Islands].
Sawai Y; Kawamura Y; Fukuyama T; Kawai J; Shimizu T
Nihon Saikingaku Zasshi; 1966 Feb; 21(2):88-91. PubMed ID: 6005977
[No Abstract] [Full Text] [Related]
3. Immunogenicity of purified Habu snake-venom toxoid in guinea pigs and monkeys with special reference to HR1 component.
Sadahiro S; Omori-Satoh T; Yamauchi K; Kondo S; Ishida S; Murata R
Jpn J Med Sci Biol; 1981 Aug; 34(4):213-30. PubMed ID: 6798252
[TBL] [Abstract][Full Text] [Related]
4. [Detection of anti-horse serum antibody produced by injecting an antivenin or antitoxin (Report 2)].
Ameno S; Ameno K; Fuke C; Kiryu T; Sogo K; Yodoya J; Ijiri I; Tsunenari S
Nihon Hoigaku Zasshi; 1988 Apr; 42(2):161-8. PubMed ID: 3172555
[No Abstract] [Full Text] [Related]
5. The Protobothrops flavoviridis Hemorrhagic Metalloproteinase HR2 Is Inhibited by Human Alpha 2-Macroglobulin.
Morine N; Matsuda S; Izumi Y; Oshiro A; Kudaka J
Jpn J Infect Dis; 2018 Jul; 71(4):286-290. PubMed ID: 29709984
[TBL] [Abstract][Full Text] [Related]
6. Preparación toxoide a partir de la fracción hemorrágica del veneno de Bothrops asper (serpiente de América Central y del Sur) (Toxoid preparation from hemorrhagic fraction of the venom from Bothrops asper (snake from Central and South America).
Rodríguez-Acosta A; Aguilar I; Girón ME
Rev Cubana Med Trop; 1993; 45(1):16-9. PubMed ID: 7800884
[TBL] [Abstract][Full Text] [Related]
7. Immune response of man to Habu-venom toxoid.
Murata R; Fukushima H
Jpn J Med Sci Biol; 1981 Aug; 34(4):197-212. PubMed ID: 7321293
[TBL] [Abstract][Full Text] [Related]
8. [Basic studies on habu snake (Trimeresurus flavoviridis) venom toxoid. 1. On the immunogenicity of the toxoid].
Sawai Y; Kawamura Y; Makino M; Fukuyama T; Okonogi T
Nihon Saikingaku Zasshi; 1966 Jan; 21(1):32-41. PubMed ID: 5333563
[No Abstract] [Full Text] [Related]
9. Studies on the improvement of treatment of habu (Trimeresurus flavoviridis) bites. 7. Experimental studies on the habu venom toxoid by dihydrothioctic acid.
Sawai Y; Kawamura Y; Fukuyama T; Okonogi T
Jpn J Exp Med; 1969 Apr; 39(2):109-17. PubMed ID: 4904177
[No Abstract] [Full Text] [Related]
10. Studies on the improvement of treatment of Habu (Trimeresurus flavoviridis) bites. 9. Studies on the immunogenicity of the purified Habu venom toxoid by alcohol precipitation.
Sawai Y; Chinzei H; Kawamura Y; Fukuyama T; Okonogi T
Jpn J Exp Med; 1972 Apr; 42(2):155-64. PubMed ID: 4537796
[No Abstract] [Full Text] [Related]
11. Effects of pH and lysine during detoxification of a hemorrhagic principle of Habu snake (Trimeresurus flavoviridis) venom with formalin on the immunogenicity of the toxoid.
Sadahiro S; Omori-Satoh T; Kondo S; Matuhasi T
Jpn J Med Sci Biol; 1984; 37(5-6):225-31. PubMed ID: 6443133
[TBL] [Abstract][Full Text] [Related]
12. Preparation and standardization of toxoid from the venom of Trimeresurus flavoviridis (Habu).
Kondo S; Sadahiro S; Yamauchi K; Kondo H; Murata R
Jpn J Med Sci Biol; 1971 Oct; 24(5):281-94. PubMed ID: 5316782
[No Abstract] [Full Text] [Related]
13. Immunogenicity of a toxoid of Habu (Trimeresurus flavoviridis) venom in various animal species including man.
Kondo H; Sadahiro S; Kondo S; Yamauchi K; Murata R
Jpn J Med Sci Biol; 1971 Dec; 24(6):365-77. PubMed ID: 5003950
[No Abstract] [Full Text] [Related]
14. The safety of the toxoid of habu (Trimeresurus flavoviridis) venom.
Kondo H; Murata R
Jpn J Med Sci Biol; 1968 Aug; 21(4):299-300. PubMed ID: 5304279
[No Abstract] [Full Text] [Related]
15. [Preventive studies on habu snake (Trimeresurus flaviridis) bites with its venom toxoid. 2. Side-effects of the toxoid vaccination in the Ryuku Islands].
Miyagi F; Hokama Z; Yamakawa M; Miyagi E; Onishi K
Nihon Saikingaku Zasshi; 1966 Apr; 21(4):206-9. PubMed ID: 6005860
[No Abstract] [Full Text] [Related]
16. [Serological study carried out in Cambodia during a tetanus vaccination in adults].
Schlumberger M; Yvonnet B; Que HV; Chhem DB; Saliou P; Le Tu TC; Glaziou P
Bull Soc Pathol Exot; 2008 Feb; 101(1):36-42. PubMed ID: 18432006
[TBL] [Abstract][Full Text] [Related]
17. Studies on the improvement of treatment on habu (Trimeresurus flavoviridis) bites. 8. A field trial of the prophylactic inoculation of the habu venom toxoid.
Sawai Y; Kawamura Y; Fukuyama T; Okonogi T; Ebisawa I
Jpn J Exp Med; 1969 Jun; 39(3):197-203. PubMed ID: 4904502
[No Abstract] [Full Text] [Related]
18. Effects of adjuvants on the immunogenicity of Habu-venom toxoid in the monkey and the guinea pig.
Sadahiro S; Kondo S; Yamamoto A
Jpn J Med Sci Biol; 1981 Jun; 34(3):169-73. PubMed ID: 6796732
[TBL] [Abstract][Full Text] [Related]
19. Toxoid preparation from venom of Bothrops colombiensis (Central and South American snake).
Rodriquez-Acosta A; Alonso R; Castro I; Aguilar A; Giron ME
Roum Arch Microbiol Immunol; 1991; 50(3):209-14. PubMed ID: 1821162
[TBL] [Abstract][Full Text] [Related]
20. Failure of an Actinomyces pyogenes vaccine to protect sheep against an intravenous challenge.
Hunter P; van der Lugt JJ; Gouws JJ
Onderstepoort J Vet Res; 1990 Dec; 57(4):239-41. PubMed ID: 2293133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
